Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Esketamine hydrochloride by Celon Pharma for Major Depressive Disorder: Likelihood of Approval
Esketamine hydrochloride is under clinical development by Celon Pharma and currently in Phase II for Major Depressive Disorder. According to...
Data Insights
Esketamine hydrochloride by Jiangsu Hengrui Medicine for General Anesthetic Effect: Likelihood of Approval
Esketamine hydrochloride is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for General Anesthetic Effect. According...